248 related articles for article (PubMed ID: 16166103)
1. Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome.
Pertovaara M; Antonen J; Hurme M
Ann Rheum Dis; 2006 May; 65(5):666-70. PubMed ID: 16166103
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin KM and GM gene polymorphisms modify the clinical presentation of primary Sjögren's syndrome.
Pertovaara M; Hurme M; Antonen J; Pasternack A; Pandey JP
J Rheumatol; 2004 Nov; 31(11):2175-80. PubMed ID: 15517630
[TBL] [Abstract][Full Text] [Related]
3. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
[TBL] [Abstract][Full Text] [Related]
4. Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome.
Pertovaara M; Lehtimäki T; Rontu R; Antonen J; Pasternack A; Hurme M
Rheumatology (Oxford); 2004 Dec; 43(12):1484-7. PubMed ID: 15328426
[TBL] [Abstract][Full Text] [Related]
5. Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome.
Kolkowski EC; Reth P; Pelusa F; Bosch J; Pujol-Borrell R; Coll J; Jaraquemada D
J Autoimmun; 1999 Aug; 13(1):155-62. PubMed ID: 10441181
[TBL] [Abstract][Full Text] [Related]
6. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients.
Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M
Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499
[TBL] [Abstract][Full Text] [Related]
7. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.
Gottenberg JE; Sellam J; Ittah M; Lavie F; Proust A; Zouali H; Sordet C; Sibilia J; Kimberly RP; Mariette X; Miceli-Richard C
Arthritis Res Ther; 2006; 8(1):R30. PubMed ID: 16507129
[TBL] [Abstract][Full Text] [Related]
8. Th1 and Th2 polymorphisms in Sjögren's syndrome and rheumatoid arthritis.
de Souza TR; de Albuquerque Tavares Carvalho A; Duarte ÂP; Porter SR; Leão JC; Gueiros LA
J Oral Pathol Med; 2014 Jul; 43(6):418-26. PubMed ID: 24393164
[TBL] [Abstract][Full Text] [Related]
9. Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome?
Sellam J; Miceli-Richard C; Gottenberg JE; Proust A; Ittah M; Lavie F; Loiseau P; Mariette X
Rheumatology (Oxford); 2008 Apr; 47(4):437-41. PubMed ID: 18296721
[TBL] [Abstract][Full Text] [Related]
10. FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome.
Treviño-Talavera BA; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Vázquez-Del Mercado M; García de la Torre I; Oregon-Romero E
Genet Mol Res; 2014 Jul; 13(3):4831-8. PubMed ID: 25062418
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome.
Hulkkonen J; Pertovaara M; Antonen J; Pasternack A; Hurme M; Pöllänen P; Lehtimäki T
Rheumatology (Oxford); 2004 Dec; 43(12):1476-9. PubMed ID: 15316122
[TBL] [Abstract][Full Text] [Related]
13. No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome.
Ittah M; Gottenberg JE; Proust A; Hachulla E; Puechal X; Loiseau P; Mariette X; Miceli-Richard C
Genes Immun; 2005 Aug; 6(5):457-8. PubMed ID: 15933742
[TBL] [Abstract][Full Text] [Related]
14. Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome.
Gestermann N; Koutero M; Belkhir R; Tost J; Mariette X; Miceli-Richard C
Eur Cytokine Netw; 2012; 23(4):166-72. PubMed ID: 23302156
[TBL] [Abstract][Full Text] [Related]
15. Activity of T-helper cells in patients with primary Sjogren's syndrome.
Sudzius G; Mieliauskaite D; Butrimiene I; Siaurys A; Mackiewicz Z; Dumalakiene I
In Vivo; 2013; 27(2):263-8. PubMed ID: 23422488
[TBL] [Abstract][Full Text] [Related]
16. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome.
Mitsias DI; Tzioufas AG; Veiopoulou C; Zintzaras E; Tassios IK; Kogopoulou O; Moutsopoulos HM; Thyphronitis G
Clin Exp Immunol; 2002 Jun; 128(3):562-8. PubMed ID: 12067313
[TBL] [Abstract][Full Text] [Related]
17. IL-7 drives Th1 and Th17 cytokine production in patients with primary SS despite an increase in CD4 T cells lacking the IL-7Rα.
Bikker A; Moret FM; Kruize AA; Bijlsma JW; Lafeber FP; van Roon JA
Rheumatology (Oxford); 2012 Jun; 51(6):996-1005. PubMed ID: 22302060
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
Tomás S; Coll J; Reth P; Corominas JM
Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
[TBL] [Abstract][Full Text] [Related]
19. Th1 and Th2 cytokine gene polymorphisms in two indigenous ethnic groups in Iran.
Amirzargar A; Sadeghi M; Khosravi F; Dianat S; Naroueynejad M; Nicknam MH; Hatmi N; Ansaripour B; Moradi B; Nikbin B
Int J Immunogenet; 2006 Dec; 33(6):429-37. PubMed ID: 17117953
[TBL] [Abstract][Full Text] [Related]
20. Polarization of B effector cells in Sjögren's syndrome.
Daridon C; Guerrier T; Devauchelle V; Saraux A; Pers JO; Youinou P
Autoimmun Rev; 2007 Aug; 6(7):427-31. PubMed ID: 17643928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
